Vaping Cannabis Triggers Cancer, Inflammation, and Oxidative Stress Genes in Lung Cells
Cannabis vapor exposure activated gene pathways related to cancer, oxidative stress, and immune response in human lung cells—without triggering DNA damage repair, suggesting unique harm mechanisms.
Quick Facts
What This Study Found
Many people switch from smoking to vaping cannabis believing it's safer. This study tested that assumption directly by exposing human alveolar (lung) epithelial cells to cannabis vapor and analyzing which genes turned on or off.
The researchers developed a physiologically relevant exposure method using A549 lung cells maintained at an air-liquid interface (ALI)—a setup that more closely mimics actual lung tissue than traditional cell cultures submerged in liquid. They compared three exposure models of increasing sophistication.
The findings were concerning. Cannabis vapor significantly altered gene expression in pathways related to cancer, oxidative stress, and immune response. These aren't random genes—they're pathways directly relevant to lung disease development.
A particularly notable finding: the cancer and inflammatory pathway activation occurred without an associated DNA damage response. This distinguishes cannabis vapor from cigarette smoke (which causes direct DNA damage) and suggests a different harm mechanism—one that may promote cancer through inflammatory and oxidative pathways rather than through genetic mutations. Whether this makes cannabis vapor more or less dangerous than cigarette smoke long-term is an open question, but it is clearly not harmless.
The ALI-maintained cells showed higher expression of type 2 alveolar epithelial cell markers (surfactant production, ion transport, barrier integrity) at baseline, confirming the model's physiological relevance.
Key Numbers
Cannabis vapor activated gene pathways for: cancer, oxidative stress, immune response. Did NOT activate DNA damage response pathways. ALI-maintained cells showed higher AEC2 marker expression. Three exposure models compared for transcriptional response.
How They Did This
In vitro study using A549 human alveolar epithelial cells in three culture conditions: submerged, pseudo-air-liquid interface (ALI), and ALI with the expoCube advanced exposure system. Acute cannabis vapor exposure. Transcriptomic analysis (gene expression profiling) of exposed vs. control cells.
Why This Research Matters
Cannabis vaping is the fastest-growing method of consumption, particularly among young adults. The assumption that vaping is "safer than smoking" may be true for some metrics but this study shows vaporized cannabis is not biologically inert—it activates cellular pathways directly linked to cancer, inflammation, and oxidative damage in the exact cell type (alveolar epithelial) that lines the lungs.
The Bigger Picture
Most respiratory health research on cannabis has focused on smoking. As vaping becomes dominant, this study provides the first transcriptomic data on how cannabis vapor specifically affects lung cells. The inflammatory pathway activation connects to the broader cannabinoid-inflammation literature (RTHC-00184 on CBD's immunomodulatory effects, RTHC-00190 on neuroinflammation in epilepsy)—but in the lung, inflammation drives disease rather than being a therapeutic target.
What This Study Doesn't Tell Us
In vitro study using a cancer cell line (A549)—not primary human lung cells. Acute exposure may not capture chronic vaping effects. The specific cannabis product composition (THC%, terpenes, carrier liquids) isn't detailed and could affect results. No comparison to tobacco smoke or other aerosols. Gene expression changes don't necessarily translate to disease outcomes. The expoCube system, while advanced, still doesn't fully replicate in vivo pulmonary exposure.
Questions This Raises
- ?Do the transcriptomic changes translate to increased cancer risk with chronic vaping?
- ?How does cannabis vapor compare to tobacco vapor and nicotine e-cigarette aerosol at the gene expression level?
- ?Could vaporization temperature or product composition modify the harmful gene activation?
Trust & Context
- Key Stat:
- Evidence Grade:
- In vitro transcriptomic study using a physiologically relevant exposure model—provides molecular evidence but can't directly predict disease outcomes in vapers.
- Study Age:
- Published in 2025, addressing the rapidly growing cannabis vaping trend.
- Original Title:
- Transcriptomic changes in oxidative stress, immunity, and cancer pathways caused by cannabis vapor on alveolar epithelial cells.
- Published In:
- Cell biology and toxicology, 41(1), 57 (2025) — Cell Biology and Toxicology is a peer-reviewed journal focusing on cellular responses to toxic substances.
- Authors:
- Wilson, Emily T(3), Graham, Percival, Eidelman, David H(3), Baglole, Carolyn J
- Database ID:
- RTHC-07955
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07955APA
Wilson, Emily T; Graham, Percival; Eidelman, David H; Baglole, Carolyn J. (2025). Transcriptomic changes in oxidative stress, immunity, and cancer pathways caused by cannabis vapor on alveolar epithelial cells.. Cell biology and toxicology, 41(1), 57. https://doi.org/10.1007/s10565-025-09997-3
MLA
Wilson, Emily T, et al. "Transcriptomic changes in oxidative stress, immunity, and cancer pathways caused by cannabis vapor on alveolar epithelial cells.." Cell biology and toxicology, 2025. https://doi.org/10.1007/s10565-025-09997-3
RethinkTHC
RethinkTHC Research Database. "Transcriptomic changes in oxidative stress, immunity, and ca..." RTHC-07955. Retrieved from https://rethinkthc.com/research/wilson-2025-transcriptomic-changes-in-oxidative
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.